MyAverix Finance
F · Healthcare
MAGLE CHEMOSWED HOLDING (52X)
Biotechnology
MAGLE CHEMOSWED HOLDING (52X) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 52X
MAGLE CHEMOSWED HOLDING (52X) — FAQ
What is 52X's P/E ratio?
The price-to-earnings (P/E) ratio for MAGLE CHEMOSWED HOLDING (52X) is 25.00 (data as of 2026-05-23).
Does MAGLE CHEMOSWED HOLDING pay a dividend?
Dividend yield is not available in the current snapshot for MAGLE CHEMOSWED HOLDING (52X). Check the MyAverix Finance app for the latest dividend data.
What sector is MAGLE CHEMOSWED HOLDING in?
MAGLE CHEMOSWED HOLDING (52X) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 52X listed on?
52X is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.